InvestorsHub Logo
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

Re: falconer66a post# 367262

Friday, 07/22/2022 1:17:56 PM

Friday, July 22, 2022 1:17:56 PM

Post# of 462286
Yes, the S1R seems to be fantastic in its broad therapeutic value. It looks like the patent listed all possible applications of 2-73. There will be many trials run for years and years. It looks like Anavex is already moving 2-73 straight into P3 trials, so that will speed things up. As revenue rolls in, paying for many trials will not be an issue.
Once 2-73 is approved for sale, it will be interesting to how many people taking 2-73 for some problem, report improvements in unrelated health problems they have.

Hopefully, you get a 3 fer the price of one!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News